Myovant Sciences Ltd.

Ownership Transactions Reported by 13 Insiders

Industry: Pharmaceutical Preparations
Location: Suite 1, 3 Rd Floor, 11 12 St. James Square, London, United Kingdom

There are no Buy or Sell transactions made by insiders since 9/13/2023

Myovant Sciences Ltd. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Sumitomo Chemical Co., Ltd.	10%+ Owner	$1.24B			Mar 10, 2023
Frank Karbe	Principal Fin'l & Accounting	$5.73M			Jul 7, 2021
David C. Marek	Principal Executive Officer, Director				Mar 10, 2023
Juan Camilo Arjona Ferreira	Chief Medical Officer				Mar 10, 2023
Matthew Lang	General Counsel & Corp. Secy.				Mar 10, 2023
Myrtle S. Potter	Director				Mar 10, 2023
Terrie Curran	Director				Mar 10, 2023
Uneek Mehra	Principal Financial Officer				Mar 10, 2023
Shigeyuki Nishinaka	Director				Oct 21, 2022
Mark Guinan	Director				Mar 10, 2023
Adele M. Gulfo	Director				Mar 10, 2023
Lauren Merendino	Chief Commercial Officer				Mar 10, 2023
Nancy Valente	Director				Mar 10, 2023

Recent Insider Transactions by Companies or Individuals for Myovant Sciences Ltd.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.